The molecular pathology of schizophrenia-Focus on histone and DNA modifications

Brain Research Bulletin

Volumn 83, Issue 3-4, 2010, Pages 103-107

  Akbarian, Schahram ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Core histone; CpG methylation; Development; Lysine methylation; Nucleosome; Prefrontal cortex; Psychosis; Transcriptional repression

Indexed keywords

DNA; HISTONE; RNA;

BRAIN CORTEX; BRAIN DYSFUNCTION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE DISRUPTION; GENE EXPRESSION REGULATION; HUMAN; MOLECULAR DYNAMICS; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; PROTEIN MODIFICATION; REVIEW; RNA REPLICATION; SCHIZOPHRENIA;

ANIMALS; CEREBRAL CORTEX; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; PATHOLOGY, MOLECULAR; SCHIZOPHRENIA;

EID: 77954141232     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.08.018     Document Type: Review

References (83)

1. Abdolmaleky H.M., et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2005, 134B(1):60-66.
2. Abdolmaleky H.M., et al. Epigenetic alterations of the dopaminergic system in major psychiatric disorders. Methods Mol. Biol. 2008, 448:187-212.
3. Abdolmaleky H.M., et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 2006, 15(21):3132-3145.
4. Abdolmaleky H.M., Thiagalingam S., Wilcox M. Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope. Am. J. Pharmacogenomics 2005, 5(3):149-160.
5. Abel T., Zukin R.S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr. Opin. Pharmacol. 2008, 8(1):57-64.
6. Addington A.M., et al. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol. Psychiatry 2005, 10(6):581-588.
7. Akbarian S., Huang H.S. Epigenetic regulation in human brain-focus on histone lysine methylation. Biol. Psychiatry 2009, 65(3):198-203.
8. Akbarian S., Huang H.S. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res. Rev. 2006, 52(2):293-304.
9. Akbarian S., et al. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry 2005, 62(8):829-840.
10. Allis C.D., et al. New nomenclature for chromatin-modifying enzymes. Cell 2007, 131(4):633-636.
11. Al-Mahdawi S., et al. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Hum. Mol. Genet. 2008, 17(5):735-746.
12. Barski A., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129(4):823-837.
13. Benes F.M., et al. Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(52):20935-20940.
14. Berger S.L., et al. An operational definition of epigenetics. Genes Dev. 2009, 23(7):781-783.
15. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447(7143):407-412.
16. A. Bertolino, G. Blasi, The genetics of schizophrenia, Neuroscience (2009) doi:10.10.16/j.neuroscience.2009.04.038.
17. Bollati V., et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007, 67(3):876-880.
18. Bullock W.M., et al. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. Am. J. Psychiatry 2008, 165(12):1594-1603.
19. Chakravarthy S., et al. Structure and dynamic properties of nucleosome core particles. FEBS Lett. 2005, 579(4):895-898.
20. Cheng M.C., et al. Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex. Int. J. Neuropsychopharmacol. 2008, 11(2):207-216.
21. Connor C.M., Akbarian S. DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics 2008, 3(2):55-58.
22. Delisi L.E. Searching for the true genetic vulnerability for schizophrenia. Genome Med. 2009, 1(1):14.
23. Desaulniers D., et al. Comparisons of brain, uterus, and liver mRNA expression for cytochrome p450s, DNA methyltransferase-1, and catechol-o-methyltransferase in prepubertal female Sprague-Dawley rats exposed to a mixture of aryl hydrocarbon receptor agonists. Toxicol. Sci. 2005, 86(1):175-184.
24. Dracheva S., et al. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J. Neurosci. Res. 2004, 76(4):581-592.
25. Endres M., et al. DNA methyltransferase contributes to delayed ischemic brain injury. J. Neurosci. 2000, 20(9):3175-3181.
26. Fatemi S.H., et al. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and Reelin proteins in cerebellum. Schizophr. Res. 2005, 72(2-3):109-122.
27. Fraga M.F., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(30):10604-10609.
28. Gavin D.P., et al. Histone deacetylase inhibitors and candidate gene expression: an in vivo and in vitro approach to studying chromatin remodeling in a clinical population. J. Psychiatr. Res. 2009, 43(9):870-876.
29. Gavin D.P., et al. Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophr. Res. 2008, 103(1-3):330-332.
30. Grayson D.R., et al. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(26):9341-9346.
31. Guidotti A., et al. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol. Sci. 2009, 30(2):55-60.
32. Guidotti A., et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 2000, 57(11):1061-1069.
33. Guttman M., et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458(7235):223-227.
34. Hashimoto T., et al. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am. J. Psychiatry 2008, 165(4):479-489.
35. Heintzman N.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39(3):311-318.
36. Huang H.S., Akbarian S. GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS ONE 2007, 2(8):e809.
37. Huang H.S., et al. Chromatin immunoprecipitation in postmortem brain. J. Neurosci. Methods 2006, 156(1-2):284-292.
38. Huang H.S., et al. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J. Neurosci. 2007, 27(42):11254-11262.
39. Iwamoto K., et al. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 2005, 25(22):5376-5381.
40. Jablonka E., Lamb M.J. The changing concept of epigenetics. Ann. N. Y. Acad. Sci. 2002, 981:82-96.
41. Jiang Y., et al. Epigenetics in the nervous system. J. Neurosci. 2008, 28(46):11753-11759.
42. Jiang Y., et al. Isolation of neuronal chromatin from brain tissue. BMC Neurosci. 2008, 9:42.
43. Kaminsky Z., Wang S.C., Petronis A. Complex disease, gender and epigenetics. Ann. Med. 2006, 38(8):530-544.
44. Kaminsky Z.A., et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat. Genet. 2009, 41(2):240-245.
45. Klose R.J., Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 2006, 31(2):89-97.
46. Klose R.J., et al. Demethylation of histone H3K36 and H3K9 by Rph1: a vestige of an H3K9 methylation system in Saccharomyces cerevisiae?. Mol. Cell. Biol. 2007, 27(11):3951-3961.
47. Kouzarides T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 2002, 12(2):198-209.
48. Levenson J.M., Sweatt J.D. Epigenetic mechanisms in memory formation. Nat. Rev. Neurosci. 2005, 6(2):108-118.
49. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 2005, 6(4):312-324.
50. Lundorf M.D., et al. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2005, 135B(1):94-101.
51. Lupski J.R. Schizophrenia: incriminating genomic evidence. Nature 2008, 455(7210):178-179.
52. Marutha Ravindran C.R., Ticku M.K. Changes in methylation pattern of NMDA receptor NR2B gene in cortical neurons after chronic ethanol treatment in mice. Brain Res. Mol. Brain Res. 2004, 121(1-2):19-27.
53. Matevossian A., Akbarian S. A chromatin assay for human brain tissue. J. Vis. Exp. 2008, (13).
54. Matevossian A., Akbarian S. Neuronal nuclei isolation from human postmortem brain tissue. J. Vis. Exp. 2008, (20).
55. McGowan P.O., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12(3):342-348.
56. McGowan P.O., et al. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS ONE 2008, 3(5):e2085.
57. Mellios N., et al. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol. Psychiatry 2008, 65(12):1006-1014.
58. Mill J., et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 2008, 82(3):696-711.
59. Monteggia L.M., Kavalali E.T. Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission. Biol. Psychiatry 2009, 65(3):204-210.
60. Numachi Y., et al. Methamphetamine alters expression of DNA methyltransferase 1 mRNA in rat brain. Neurosci. Lett. 2007, 414(3):213-217.
61. Numachi Y., et al. Psychostimulant alters expression of DNA methyltransferase mRNA in the rat brain. Ann. N. Y. Acad. Sci. 2004, 1025:102-109.
62. Quina A.S., Buschbeck M., Di Croce L. Chromatin structure and epigenetics. Biochem. Pharmacol. 2006, 72(11):1563-1569.
63. Rampon C., et al. Effects of environmental enrichment on gene expression in the brain. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(23):12880-12884.
64. Rando O.J. Global patterns of histone modifications. Curr. Opin. Genet. Dev. 2007, 17(2):94-99.
65. Rapoport J.L., et al. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 2005, 10(5):434-449.
66. Stone J.L., et al. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455(7210):237-241. International Schizophrenia Consortium.
67. Robinson P.J., Rhodes D. Structure of the '30nm' chromatin fibre: a key role for the linker histone. Curr. Opin. Struct. Biol. 2006, 16(3):336-343.
68. Salnikow K., Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 2008, 21(1):28-44.
69. Satta R., et al. Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(42):16356-16361.
70. Maloku E., et al. Nicotinic cholinergic mechanisms in the regulation of brain DNAmethyltransferase I (DNMT1) expression. European Psychiatry 2007, 22(Suppl 1):S88.
71. Seila A.C., et al. Divergent transcription from active promoters. Science 2008, 322(5909):1849-1851.
72. Shimabukuro M., et al. Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats. Behav. Brain Funct. 2006, 2:37.
73. Siegmund K.D., et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2007, 2(9):e895.
74. Smith M. The year in human and medical genetics. Highlights of 2007-2008. Ann. N. Y. Acad. Sci. 2009, 1151:1-21.
75. Stadler F., et al. Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain. J. Neurochem. 2005, 94(2):324-336.
76. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9(6):465-476.
77. Sweatt J.D. Experience-dependent epigenetic modifications in the central nervous system. Biol. Psychiatry 2009, 65(3):191-197.
78. Tamura Y., et al. Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol. Psychiatry 2007, 12(6). pp. 519, 593-600.
79. Tochigi M., et al. Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol. Psychiatry 2008, 63(5):530-533.
80. Tsankova N., et al. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 2007, 8(5):355-367.
81. Veldic M., et al. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(1):348-353.
82. Veldic M., et al. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(6):2152-2157.
83. Weaver I.C., et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7(8):847-854.